Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report

Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Kidney Failure, Chronic*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics
  • Vaccination

Substances

  • Spike Glycoprotein, Coronavirus